NLRP3 agonist enhances radiation-induced immune priming and promotes abscopal responses in anti-PD1 resistant model
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
NLRP3 agonist enhances radiation-induced immune priming and promotes abscopal responses in anti-PD1 resistant model ; volume:72 ; number:9 ; day:8 ; month:6 ; year:2023 ; pages:3003-3012 ; date:9.2023
Cancer immunology immunotherapy ; 72, Heft 9 (8.6.2023), 3003-3012, 9.2023
- Creator
-
Barsoumian, Hampartsoum B.
He, Kewen
Hsu, Ethan
Bertolet, Genevieve
Sezen, Duygu
Hu, Yun
Riad, Thomas S.
Cortez, Maria Angelica
Welsh, James W.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00262-023-03471-x
- URN
-
urn:nbn:de:101:1-2023110209324155038370
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:44 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Barsoumian, Hampartsoum B.
- He, Kewen
- Hsu, Ethan
- Bertolet, Genevieve
- Sezen, Duygu
- Hu, Yun
- Riad, Thomas S.
- Cortez, Maria Angelica
- Welsh, James W.
- SpringerLink (Online service)
Other Objects (12)
Agonist redirected checkpoint, PD1-Fc-OX40L, for cancer immunotherapy
The E3 ubiquitin ligase Pellino2 mediates priming of the NLRP3 inflammasome
Activation of NLRP3 inflammasome in lung epithelial cells triggers radiation-induced lung injury
Priming und Aktivierung des NLRP3-Inflammasoms in retinalen Pigmentepithelzellen unter hyperosmolaren Bedingungen
PD1 ligand functionality a biomarker of response to anti PD1 treatment in patients with HNSCC
Priming
Priming
Multifunctional carbomer based ferulic acid hydrogel promotes wound healing in radiation-induced skin injury by inactivating NLRP3 inflammasome
Response to PD1 inhibition in conventional chondrosarcoma
P2Y1 receptor signaling contributes to high salt-induced priming of the NLRP3 inflammasome in retinal pigment epithelial cells
Cardiotoxicity associated with CTLA4 and PD1 blocking immunotherapy
Cardiotoxicity associated with CTLA4 and PD1 blocking immunotherapy
Agonist redirected checkpoint, PD1-Fc-OX40L, for cancer immunotherapy
The E3 ubiquitin ligase Pellino2 mediates priming of the NLRP3 inflammasome
Activation of NLRP3 inflammasome in lung epithelial cells triggers radiation-induced lung injury
Priming und Aktivierung des NLRP3-Inflammasoms in retinalen Pigmentepithelzellen unter hyperosmolaren Bedingungen
PD1 ligand functionality a biomarker of response to anti PD1 treatment in patients with HNSCC
Priming
Priming
Multifunctional carbomer based ferulic acid hydrogel promotes wound healing in radiation-induced skin injury by inactivating NLRP3 inflammasome
Response to PD1 inhibition in conventional chondrosarcoma
P2Y1 receptor signaling contributes to high salt-induced priming of the NLRP3 inflammasome in retinal pigment epithelial cells
Cardiotoxicity associated with CTLA4 and PD1 blocking immunotherapy
Cardiotoxicity associated with CTLA4 and PD1 blocking immunotherapy
Agonist redirected checkpoint, PD1-Fc-OX40L, for cancer immunotherapy
The E3 ubiquitin ligase Pellino2 mediates priming of the NLRP3 inflammasome
Activation of NLRP3 inflammasome in lung epithelial cells triggers radiation-induced lung injury
Priming und Aktivierung des NLRP3-Inflammasoms in retinalen Pigmentepithelzellen unter hyperosmolaren Bedingungen
PD1 ligand functionality a biomarker of response to anti PD1 treatment in patients with HNSCC
Priming
Priming
Multifunctional carbomer based ferulic acid hydrogel promotes wound healing in radiation-induced skin injury by inactivating NLRP3 inflammasome
Response to PD1 inhibition in conventional chondrosarcoma
P2Y1 receptor signaling contributes to high salt-induced priming of the NLRP3 inflammasome in retinal pigment epithelial cells
Cardiotoxicity associated with CTLA4 and PD1 blocking immunotherapy